Tue, November 23, 2021
Mon, November 22, 2021
Sun, November 21, 2021
Sat, November 20, 2021
Fri, November 19, 2021
Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021
Mon, November 15, 2021

Thomas Smith Initiated (VRDN) at Buy and Held Target at $32 on, Nov 18th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-32-on-nov-18th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Thomas Smith of SVB Leerink, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $32 on, Nov 18th, 2021.

Thomas has made no other calls on VRDN in the last 4 months.



There are 2 other peers that have a rating on VRDN. Out of the 2 peers that are also analyzing VRDN, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Thomas


  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $36 on, Friday, November 5th, 2021
  • Maneka Mirchandaney of "Evercore ISI Group" Initiated at Buy and Held Target at $40 on, Tuesday, October 12th, 2021

Publication Contributing Sources